Sun Pharma is stepping up regulatory compliance efforts at three USFDA-flagged facilities, including Halol, Mohali, and Dadra.

Sun Pharma aims to enhance compliance and R&D investment for global speciality products, targeting mid to high single-digit ...

Sun Pharmaceutical Industries is addressing regulatory issues at three facilities, including an import alert at Halol.

Sun Pharma is working to resolve USFDA compliance issues at three facilities: Halol, Mohali, and Dadra. The company is implementing CAPA and anticipates mid to high single-digit growth in FY26.

Mumbai: Sun Pharma Advanced Research Company Limited (SPARC) has announced the incorporation of its wholly owned subsidiary, ...

Sun Pharma appoints Richard Ascroft as North America CEO to lead U.S. and Canada operations, including new drug launches and ...

Similarly, Aurobindo Pharma is recalling 13,605 bottles of Clorazepate Dipotassium Tablets (3.75 mg and 7.5 mg) from the US market. Clorazepate Dipotassium Tablets are used to treat anxiety.

Shift is expected to drive a sharp increase in generic drug launches, positioning Indian drugmakers for strong growth ...

Sun Pharmaceutical Industries Limited has announced appointment of Kirti Ganorkar as the Managing Director to succeed Dilip Shanghvi, effective September 1, 2025, with the entire business and all ...

Sun Pharmaceutical Industries has signalled change and succession planning with its appointment of Kirti Ganorkar as Managing Director, succeeding the Founder Dilip Shanghvi, from September 1, 2025.

India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics , a U.S.-based immunotherapy and targeted oncology company, for $355 million.